Femme et Homme
- | Pays :
- Poland
- Taiwan, Province of China
- Mexico
- Les 6 autres...
- | Organes : -
- | Spécialités : -
Extrait
This randomized, double-blind, placebo-controlled, parallel group study will evaluate the safety and efficacy of RO4917523 as adjunctive therapy in patients with major depressive disorder and an inadequate response to ongoing antidepressant therapy. Anticipated time on study treatment is 6 weeks with a 3-week follow-up.
Critère d'inclusion
- Major Depressive Disorder